Stoke Therapeutics Inc (STOK) — Financial Flexibility Index
Stoke Therapeutics Inc (STOK) has a Financial Flexibility Index of -1.24x as of March 2026. Free cash flow of $-60.23 Million (operating CF $-60.58 Million minus capex $353.00K) represents -1% of total liabilities ($48.40 Million). Check STOK PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Stoke Therapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Stoke Therapeutics Inc across 9 annual periods. See Stoke Therapeutics Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Stoke Therapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Stoke Therapeutics Inc. For the full company profile including market capitalisation, see market cap of Stoke Therapeutics Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.70x | $46.26 Million | $45.59 Million | $65.98 Million | ▲ +134.4% |
| 2024 | -2.04x | $-86.65 Million | $-86.85 Million | $42.53 Million | ▼ -76.3% |
| 2023 | -1.16x | $-79.45 Million | $-81.07 Million | $68.78 Million | ▼ -194.8% |
| 2022 | -0.39x | $-27.90 Million | $-31.87 Million | $71.22 Million | ▲ +87.4% |
| 2021 | -3.12x | $-65.71 Million | $-66.91 Million | $21.09 Million | ▲ +10.3% |
| 2020 | -3.48x | $-41.17 Million | $-42.22 Million | $11.85 Million | ▲ +48.9% |
| 2019 | -6.81x | $-29.42 Million | $-31.05 Million | $4.32 Million | ▼ -67.7% |
| 2018 | -4.06x | $-10.03 Million | $-10.96 Million | $2.47 Million | ▼ -187.3% |
| 2017 | -1.41x | $-5.27 Million | $-5.38 Million | $3.73 Million | — |